logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

KINGDEE INT'L (00268) spent 2.67 million Hong Kong dollars to repurchase 500,000 shares on September 17th.

date
17:32 17/09/2024
avatar
GMT Eight
Golden Butterfly International (00268) announced that the company spent 2.67 million Hong Kong dollars to repurchase 5...
KINGDEE INT'L(00268) announced that the company has repurchased 500,000 shares at a price of 5.3-5.4 Hong Kong dollars per share for a total of 2.67 million Hong Kong dollars on September 17, 2024.
Related Articles
China Stock
Hua Chuang Securities: Food and Beverage Bottoming Out, Position in Leading Players for Recovery
China Stock
Guosen: Evolution of Open Models and Agent Applications; Bullish on AI Applications, Film and Television Content, and IP Trendy Toy Opportunities
US Stock
Amgen (AMGN.US) and Astrazeneca PLC Sponsored ADR (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reducing risk of death by 58%
Hua Chuang Securities: Food and Beverage Bottoming Out, Position in Leading Players for Recovery
China Stock
Guosen: Evolution of Open Models and Agent Applications; Bullish on AI Applications, Film and Television Content, and IP Trendy Toy Opportunities
China Stock
Amgen (AMGN.US) and Astrazeneca PLC Sponsored ADR (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reducing risk of death by 58%
US Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.